Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
110 USD | +3.58% | -.--% | -12.00% |
02:17pm | Collective bargaining partners in the chemical industry adjourn again | DP |
05-31 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
Sales 2024 * | 6.14B 6.67B 522B | Sales 2025 * | 6.6B 7.17B 561B | Capitalization | 5.02B 5.45B 427B |
---|---|---|---|---|---|
Net income 2024 * | 225M 244M 19.13B | Net income 2025 * | 413M 449M 35.12B | EV / Sales 2024 * | 0.86 x |
Net Debt 2024 * | 251M 273M 21.37B | Net Debt 2025 * | 197M 214M 16.75B | EV / Sales 2025 * | 0.79 x |
P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
12.5
x | Employees | 16,425 |
Yield 2024 * |
2.44% | Yield 2025 * |
4.02% | Free-Float | 31.67% |
Latest transcript on Wacker Chemie AG
1 day | +3.58% | ||
1 month | -0.27% | ||
3 months | -1.13% | ||
6 months | -7.33% | ||
Current year | -12.00% |
Managers | Title | Age | Since |
---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 31/10/15 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 31/12/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 07/05/08 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 07/05/08 |
Susanne Weiss
BRD | Director/Board Member | 63 | 07/05/08 |
Date | Price | Change | Volume |
---|---|---|---|
29/05/24 | - | +-NaN% | 640 |
Delayed Quote OTC Markets, May 24, 2024 at 04:14 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.43% | 19.8B | |
+2.13% | 4.16B | |
+13.23% | 1.54B | |
-2.65% | 1.26B | |
+16.44% | 943M | |
-17.41% | 658M | |
-38.91% | 550M | |
-22.36% | 274M | |
-6.04% | 252M |
- Stock Market
- Equities
- WCH Stock
- WKCMF Stock